Project Grant 2110980
Award Date
8/1/21
Completion Date
7/31/22
Dollars Obligated
$251K
Federal Agency
Division of Industrial Innovation
Awardee
Sequegenics LLC (SCEMGWUPA375)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
Micropure Genomics Inc. received a $274,199 Project Grant award from the National Science Foundation to advance methods for rapid, end-to-end sample preparation for sequencing applications. Under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the company will develop an automated process relying on electro-hydrodynamic trapping to isolate genomic material like DNA or RNA from cells in a flow cartridge. The process aims to significantly reduce preparation time while...
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a revolutionary DNA sequencing platform by Xgenomes Corp. The $384,418 award, active from September 2024 to May 2025, aims to construct a proof-of-concept for a super-resolution, single-molecule sequencing technology that can read short sequence "words" rather than individual nucleotides. The proposed approach uses advanced statistical and...
This National Science Foundation (NSF) Cooperative Agreement award, funded under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $1,250,000 to Micropure Genomics Inc., a minority-owned small business, to develop an innovative automated platform for preparing high-quality DNA samples for long-read sequencing applications. The project aims to address critical barriers in genomic sequencing by advancing a novel technology for DNA sample preparation. Key...
This $900,000 Project Grant, awarded by the National Science Foundation's (NSF) Computer and Information Science and Engineering (CFDA 47.070) program, supports the development of custom hardware accelerators and software solutions to enable pervasive use of genome sequencing in precision healthcare. The three key objectives are: 1) designing domain-specific accelerators for whole genome sequencing and emerging genomics applications, 2) developing point-of-care pathogen detectors using real-time...
This Project Grant award of $408,007 from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop a technology called "glycosequencing" that uses next-generation sequencing (NGS) to sequence and quantify glycan structures. The project will first identify an optimal set of lectins, biochemically characterize them, and prepare lectin barcoding for NGS. It will also build a training dataset using recombinant proteins produced in glycoengineered Chinese...
This Project Grant award from the National Institutes of Health's National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $406,500 to Directseq Biosciences, Inc. to advance their next-generation mass spectrometry-based sequencing (NGMS-SEQ) methods for high-throughput direct sequencing and quantitative mapping of RNA modifications. The key objectives are to: 1) enhance NGMS-SEQ techniques to enable direct sequencing of various tRNA samples, including...
The National Human Genome Research Institute (NHGRI), under the Federal Grant Program "Human Genome Research" (CFDA 93.172), awarded a $407,291 Phase I Small Business Innovation Research (SBIR) grant to Electronic Biosciences, Inc. to develop a nanopore-based protein sequencing platform. The project aims to create a high-accuracy, label-free nanopore reader capable of direct, single-molecule protein sequencing. This novel technology would enable proteome-wide profiling, biomarker...
This Project Grant award from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) provides $215,088 to Directseq Biosciences, Inc. to develop and test an "Exhaustive De Novo Sequencing of Every RNA in a Sample by a Layer-by-Layer Mass Spectrometry Ladder Intensity Approach." The project aims to create a comprehensive RNA sequencing and modification profiling method that can identify and sequence all RNA species in a sample...
The federal Project Grant award R43GM156154 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $350,000 award supports the development of a neural network-accelerated DNA and RNA sequence processing node, called CLEDGESEQ, that can be used for distributed next-generation sequencing (NGS) data processing at the point of sequencing. The goal is to create a cost-effective and scalable...
This $639,794 federal grant award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the acquisition of an Illumina NextSeq 2000 next-generation DNA sequencing instrument for the Design, Automation, Manufacturing, and Process (DAMP) Laboratory at Boston University. The new sequencing instrument will enable DAMP Lab researchers to study the genomic sequences of novel molecular tools they are developing, which can lead to improvements in drug design,...